Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

Conditions:   Connective Tissue Diseases;   Thrombocytopenia Interventions:   Biological: Telitacicept;   Drug: Placebo Sponsors:   Beijing Hospital;   The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial);   Peking University People's Hospital;   Peking University Third Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Guangdong Provincial People's  Hospital;   The First Affiliated Hospital of Zhengzhou University;   Wuhan Union Hospital, China;   Second Xiangya Hospital of Central South University;   Xiangya Hospital of Central South University;   The Affiliated Hospital of Inner Mongolia Medical University;   First Hospital of  China Medical University;   Shandong Provincial Hospital;   Changhai Hospital;   RenJi Hospital;   Shanxi Bethune Hospital;   West China Hospital;   Institute of Hematology & Blood Diseases Hospital;   Tianjin First Central Hospital;   Tianjin Medical University General Hospital;   People's Hospital of Xinjiang Uygur Autonomous Region;   The First People's Hospital of Yunnan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials